Kolexia
Canoui Etienne
Médecine interne
Hôpital Cochin
Paris, France
109 Activités
121 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Endophtalmie Abcès Maladies transmissibles Fièvre Abcès du foie Pneumopathie infectieuse Lymphomes Infections urinaires

Industries

Axess Research
9 collaboration(s)
Dernière en 2023
WorldOne
4 collaboration(s)
Dernière en 2020
Pfizer
3 collaboration(s)
Dernière en 2023
Medicys Limited
2 collaboration(s)
Dernière en 2023

Dernières activités

β-Lactam Allergy Management: A Practical Approach for Clinical Decision-Making
Anaesthesia, critical care & pain medicine   11 mars 2024
Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study.
Open forum infectious diseases   09 janvier 2024
ICODIA: Complex Ocular Infection, Optimization of Microbiological Diagnosis
Essai Clinique (Assistance publique – Hôpitaux de Paris)   24 novembre 2023
Defining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study.
The Journal of antimicrobial chemotherapy   10 novembre 2023
Manifestaciones ORL de la tuberculosis
EMC - Otorrinolaringología   01 novembre 2023
Can Chatbot artificial intelligence replace infectious disease physicians in the management of bloodstream infections? A prospective cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   12 octobre 2023
Isolated conjugated hyperbilirubinemia with rifampicin and cross-reaction with rifabutin: A drug-endogenous substance interaction case report.
Therapie   10 octobre 2023
Leprosy combined with vitiligo skin lesions.
La Revue de medecine interne   09 octobre 2023
Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?
The Journal of antimicrobial chemotherapy   09 octobre 2023
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
The Journal of antimicrobial chemotherapy   06 septembre 2023